
Blend · Vial
CJC-1295 + Ipamorelin
From CA$129A two-peptide blend used to explore how different signals influence the body’s growth-hormone system.

Growth hormone research
Explore products related to growth-hormone signalling and see which compounds, formulations and populations were actually studied.
Start here
Growth-hormone research spans distinct compounds, mechanisms and study settings. This collection keeps those differences attached to the material so a controlled clinical finding is not mistaken for evidence about a separate research product or combination.
Related products

Blend · Vial
A two-peptide blend used to explore how different signals influence the body’s growth-hormone system.

Peptide · Vial
A synthetic peptide that mimics a natural signal involved in the release of growth hormone.

Peptide · Vial
A long-acting GHRH analogue with a Drug Affinity Complex (DAC) that binds albumin, studied in growth-hormone signalling research.

Peptide · Vial
A selective growth-hormone secretagogue pentapeptide studied in growth-hormone signalling research.

Peptide · Vial
A long-acting analogue of insulin-like growth factor 1, widely used as a supplement in cell-culture research.

Blend · Vial
A two-peptide blend of tesamorelin and ipamorelin (18mg total), explored in growth-hormone signalling research.

Peptide · Vial
A 29-amino-acid analogue of growth-hormone-releasing hormone (GHRH 1–29), studied in growth-hormone axis research.

Peptide · Vial
A modified form of growth-hormone-releasing hormone (GHRH 1–29), also called Mod GRF 1-29, studied in growth-hormone signalling research.

Peptide · Vial
A synthetic hexapeptide growth-hormone secretagogue, also known as pralmorelin, that acts on the ghrelin receptor.

Peptide · Vial
One of the first synthetic hexapeptide growth-hormone secretagogues, acting on the ghrelin receptor.

Peptide · Vial
A truncated form of insulin-like growth factor 1 lacking its first three amino acids, used in cell-culture research.

Peptide · Vial
Recombinant human growth hormone (somatropin), a 191-amino-acid protein studied in growth-hormone and IGF-1 signalling research.

Peptide · Vial
A synthetic hexapeptide growth-hormone secretagogue that acts on the ghrelin receptor.
Bundle · 5 vials
2 × CJC-1295 No DAC 5mg and 3 × Ipamorelin 5mg, bundled at 19% below the individual vial prices.
2 vialsCJC-1295 with DACBundle · 6 vials
2 × 5-Amino-1MQ 10mg, 2 × Ipamorelin 5mg and 2 × CJC-1295 with DAC 5mg, bundled at 11% below the individual vial prices.
5 vialsCJC-1295 with DAC
3 vialsIGF-1LR3Bundle · 11 vials
5 × CJC-1295 with DAC 5mg, 3 × IGF-1LR3 1mg and 3 × Ipamorelin 5mg, bundled at 26% below the individual vial prices.
3 vialsTesamorelinBundle · 6 vials
3 × Ipamorelin 5mg and 3 × Tesamorelin 10mg, bundled at 18% below the individual vial prices.
2 vialsIGF-1LR3Bundle · 16 vials
10 × HGH (Somatropin) 10 IU, 4 × Hexarelin Acetate 5mg and 2 × IGF-1LR3 1mg, bundled at 19% below the individual vial prices.
2 vialsIGF-1LR3Bundle · 12 vials
10 × HGH (Somatropin) 10 IU and 2 × IGF-1LR3 1mg, bundled at 13% below the individual vial prices.
Understand the context

Clinical-trial review · 12 min
A plain-language reading of the phase 3 programme in adults living with HIV and excess abdominal fat.
Read the guide
Clinical-trial review · 10 min
Why the prespecified primary outcome matters when a randomized proof-of-concept study does not find a significant difference.
Read the guide
Early human research · 9 min
A careful reading of the randomized early-phase study: biomarkers, short follow-up and the limits of a healthy-volunteer trial.
Read the guideCheck the exact batch